Hospital
Mercy Hospital Ozark
Mercy Hospital Ozark was paid $839K by Medicaid between Jan 2018 and Dec 2024, across 70 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 14% of everything it billed.
33Billing provider infoMERCY HOSPITAL OZARK
OZARK, AR 72949
OZARK, AR 72949
33aNPI1275504128assigned 01/30/2006
33bProvider typeCritical Access Hospital
28Total paid$839K
24GClaims48,738
24DCodes billed70
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Arkansas
Rank by total paid#16 of 34
Median peer was paid$773K
This provider vs. median1.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official CLOUSE DAY, SHERRY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,831 | $90K | |
| 2019 | 6,516 | $101K | |
| 2020 | 6,220 | $103K | |
| 2021 | 5,905 | $114K | |
| 2022 | 7,270 | $144K | |
| 2023 | 9,454 | $175K | |
| 2024incomplete | 7,542 | $111K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 14% | 4,468 | 3,895 | $118K |
| 70450 | Computed tomography, head or brain; without contrast material | 11% | 726 | 658 | $89K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 7.4% | 1,703 | 1,604 | $62K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.0% | 6,258 | 5,217 | $50K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.9% | 271 | 257 | $50K |
| 84484 | 4.2% | 1,580 | 1,303 | $36K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.9% | 1,487 | 1,252 | $32K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.5% | 886 | 208 | $30K |
| 71046 | Radiologic examination, chest; 2 views | 3.2% | 1,257 | 1,162 | $27K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.0% | 292 | 247 | $25K |
| 36415 | Collection of venous blood by venipuncture | 2.9% | 1,732 | 1,367 | $24K |
| 83880 | 2.8% | 964 | 833 | $24K |
58 more codes
| 80306 | 2.7% | 1,232 | $22K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.5% | 960 | $21K |
| 87400 | 2.3% | 1,629 | $19K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.1% | 1,975 | $18K |
| 83605 | 2.0% | 1,104 | $17K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.0% | 244 | $16K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.6% | 1,172 | $13K |
| 83690 | 1.5% | 1,081 | $13K | |
| 83735 | 1.5% | 1,502 | $12K | |
| 71045 | Radiologic examination, chest; single view | 1.4% | 1,314 | $11K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.3% | 239 | $11K |
| 81025 | <1% | 881 | $8K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 43 | $8K |
| 87081 | <1% | 817 | $8K | |
| 81001 | <1% | 1,772 | $7K | |
| 80061 | Lipid panel | <1% | 658 | $6K |
| 81003 | <1% | 1,402 | $6K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 577 | $5K |
| 99285 | Emergency room visit (most serious) | <1% | 243 | $5K |
| 85610 | <1% | 1,136 | $4K | |
| 80050 | General health panel | <1% | 119 | $4K |
| 87807 | <1% | 308 | $4K | |
| 86140 | <1% | 599 | $3K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 65 | $3K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 71 | $3K |
| 85730 | <1% | 454 | $3K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 836 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 314 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 445 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 241 | $2K |
| 71020 | <1% | 120 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 719 | $1K |
| 87040 | <1% | 76 | $1K | |
| 87077 | <1% | 96 | $1K | |
| 99283 | Emergency room visit (moderate) | <1% | 14 | $1K |
| 84145 | <1% | 66 | $976.72 | |
| 82077 | <1% | 62 | $960.81 | |
| 82962 | <1% | 68 | $715.18 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 15 | $712.43 |
| 87186 | <1% | 96 | $709.90 | |
| 85379 | <1% | 38 | $394.87 | |
| 99284 | Emergency room visit (serious) | <1% | 18 | $379.35 |
| 80320 | <1% | 34 | $377.00 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 660 | $366.05 |
| 73130 | <1% | 13 | $256.75 | |
| 82728 | <1% | 12 | $238.22 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 702 | $198.83 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 410 | $197.94 |
| 85651 | <1% | 16 | $115.32 | |
| 87088 | <1% | 16 | $94.63 | |
| 84439 | <1% | 12 | $51.52 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 40 | $9.10 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 45 | $5.06 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 14 | $3.28 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 232 | $0.00 |
| A9270 | Non-covered item or service | 0% | 56 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 14 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCLOUSE DAY, SHERRY (VP FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Mercy Hospital Carthage | Carthage, MO | $18.78M |
| Mercy Hospital Aurora | Aurora, MO | $9.91M |
| Mercy Hospital Cassville | Cassville, MO | $9.56M |
| Mercy Hospital Logan County INC | Guthrie, OK | $5.02M |
| Mercy Hospital Berryville | Berryville, AR | $2.86M |
| Mercy Hospital Healdton, INC. | Healdton, OK | $1.45M |
| Mercy Hospital Booneville | Booneville, AR | $1.31M |
| Mercy Hospital Watonga INC | Watonga, OK | $1.17M |
| Mercy Hospital Waldron | Waldron, AR | $1.17M |
| Mercy Hospital Perry | Perryville, MO | $1.05M |
| Mercy Hospital Logan County, INC | Guthrie, OK | $924K |
| Mercy Hospital Paris | Paris, AR | $834K |
| Mercy Hospital Carthage | Carthage, MO | $788K |
| Mercy Hospital Kingfisher, INC | Kingfisher, OK | $385K |
| Mercy Hospital Paris | Paris, AR | $363K |
| Mercy Hospital Ozark | Ozark, AR | $268K |
| Mercy Hospital Booneville | Booneville, AR | $200K |
| Mercy Hospital Paris | Paris, AR | $152K |
| Mercy Hospital Waldron | Waldron, AR | $150K |
| Mercy Hospital Perry | Perryville, MO | $131K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.